Andrew Mulberg M.D., Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Mulberg, MD, is a pediatric gastroenterologist with nearly 30 years of experience and a strong passion for helping bring important new medicines to market for patients with devastating rare diseases. Prior to joining Neurogene, Dr. Mulberg’s industry experience included leading global regulatory affairs for Amicus Therapeutics, and various roles of increasing responsibility within global drug development and medical affairs at Johnson & Johnson. In addition to Dr. Mulberg’s biotechnology and pharmaceutical experience, he served as Division Deputy Director for six years in the Division of Gastroenterology and Inborn Errors Products at the U.S. FDA. He received his B.A. from Columbia University and his M.D. from Mount Sinai School of Medicine and served as Attending Physician and Fellowship Director of Gastroenterology and Hepatology at Children’s Hospital of Philadelphia. Dr. Mulberg is currently an adjunct Professor of Pediatrics at the University of Maryland Medical Center and Chairman of the Medical Advisory Board Go4 the Goal foundation, a pediatric cancer advocacy 501c3 organization.